Neurol Sr (Alprazolam)

Alprazolam, the active ingredient in Neurol Sr, is a benzodiazepine presented as an oral tablet for oral use. It treats anxiety disorders, panic disorder and generalized anxiety disorder in adult patients. GNH USA supplies Neurol Sr as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Alprazolam acts on the central nervous system to relieve symptoms of anxiety‑related conditions. - Anxiety disorders: reduces excessive worry and tension. - Panic disorder: alleviates sudden episodes of intense fear. - Generalized anxiety disorder: controls chronic, pervasive anxiety.

Alprazolam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness - Dizziness - Fatigue - Impaired coordination

Serious or Rare Side Effects: - Respiratory depression - Dependence or addiction - Severe withdrawal symptoms - Allergic reactions such as rash or angioedema

When prescribing alprazolam, clinicians should consider several safety measures. - Assess risk of dependence: evaluate patient history before initiating therapy. - Avoid abrupt discontinuation: taper dose under medical supervision. - Monitor for respiratory depression: especially in patients with pulmonary disease. - Caution in elderly: increased sensitivity to sedation and falls. - Store at ambient temperature: keep in original container, protect from moisture and light.

Alprazolam interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid): - CNS depressants: may cause profound sedation. - Opioids: increased risk of respiratory depression. - Alcohol: enhances sedative effects. - Azole antifungals (e.g., ketoconazole): may raise alprazolam plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase plasma concentrations. - CYP3A4 inducers (e.g., rifampin): may reduce therapeutic effect. - Antidepressants (e.g., SSRIs): may augment sedation.